Ameriprise Financial Inc Karyopharm Therapeutics Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.68 - $1.31 $31,967 - $61,584	-47,011 Reduced 13.17%	309,967 $266,000
Q3 2023 Nov 14, 2023	SELL	$1.14 - $1.81 $3,610 - $5,732	-3,167 Reduced 0.88%	356,978 $478,000
Q2 2023 Aug 14, 2023	BUY	$1.79 - $4.59 $183,097 - $469,506	102,289 Added 39.67%	360,145 $644,000
Q1 2023 May 15, 2023	BUY	$2.84 - $3.92 $263,742 - $364,038	92,867 Added 56.29%	257,856 $1 Million
Q4 2022 Feb 14, 2023	SELL	$2.48 - $5.93 $12,499 - $29,887	-5,040 Reduced 2.96%	164,989 $560,000
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $693,718 - $989,568	170,029 New	170,029 $929,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.